APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Therapy in CNS Disorder

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gene Therapy in CNS Disorder Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025189 pages

Choose your research edition.

Industry ResearchGene Therapy in CNS Disorder Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Therapy in CNS Disorder Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Gene Therapy in CNS Disorder Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Therapy in CNS Disorder Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Gene Therapy in CNS Disorder Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Gene Therapy in CNS Disorder market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Gene Therapy in CNS Disorder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gene Therapy in CNS Disorder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gene Therapy in CNS Disorder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gene Therapy in CNS Disorder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gene Therapy in CNS Disorder include Novartis AG, Biogen, Voyager Therapeutics, Spark Therapeutics and Bluebird Bio Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Gene Therapy in CNS Disorder market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gene Therapy in CNS Disorder and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gene Therapy in CNS Disorder revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Gene Therapy in CNS Disorder market size, projected growth trends, production technologies, key applications, and end-use industries.

Gene Therapy in CNS Disorder Segment by Company

Novartis AG

Biogen

Voyager Therapeutics

Spark Therapeutics

Bluebird Bio Inc.

Gene Therapy in CNS Disorder Segment by Type

Viral Gene Therapy

Non-viral Gene Therapy

Gene Therapy in CNS Disorder Segment by Application

Parkinson's Disease

Huntington's Disease

Batten Disease

Alzheimer's Disease

Gene Therapy in CNS Disorder Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Therapy in CNS Disorder market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Therapy in CNS Disorder and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Therapy in CNS Disorder.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Gene Therapy in CNS Disorder in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Therapy in CNS Disorder industry.

Chapter 3: Detailed analysis of Gene Therapy in CNS Disorder companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Therapy in CNS Disorderrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gene Therapy in CNS Disorder Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Viral Gene Therapy Table 3. Key Players of Non-viral Gene Therapy Table 4. Global Gene Therapy in CNS Disorder Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Parkinson's Disease Table 6. Key Players of Huntington's Disease Table 7. Key Players of Batten Disease Table 8. Key Players of Alzheimer's Disease Table 9. Global Gene Therapy in CNS Disorder Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Gene Therapy in CNS Disorder Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Gene Therapy in CNS Disorder Market Share by Region (2021-2026) Table 12. Global Gene Therapy in CNS Disorder Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Gene Therapy in CNS Disorder Market Share by Region (2027-2032) Table 14. Gene Therapy in CNS Disorder Industry Trends Table 15. Gene Therapy in CNS Disorder Industry Drivers Table 16. Gene Therapy in CNS Disorder Industry Opportunities and Challenges Table 17. Gene Therapy in CNS Disorder Industry Restraints Table 18. Global Gene Therapy in CNS Disorder Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Gene Therapy in CNS Disorder Revenue Market Share by Company (2021-2026) Table 20. Global Gene Therapy in CNS Disorder Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Gene Therapy in CNS Disorder Key Company Head Office and Area Served Table 22. Global Gene Therapy in CNS Disorder Company, Product Type & Application Table 23. Global Gene Therapy in CNS Disorder Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Gene Therapy in CNS Disorder by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Gene Therapy in CNS Disorder Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Gene Therapy in CNS Disorder Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Gene Therapy in CNS Disorder Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Gene Therapy in CNS Disorder Revenue Market Share by Type (2021-2026) Table 30. Global Gene Therapy in CNS Disorder Revenue Market Share by Type (2027-2032) Table 31. Global Gene Therapy in CNS Disorder Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Gene Therapy in CNS Disorder Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Gene Therapy in CNS Disorder Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Gene Therapy in CNS Disorder Revenue Market Share by Application (2021-2026) Table 35. Global Gene Therapy in CNS Disorder Revenue Market Share by Application (2027-2032) Table 36. Novartis AG Company Information Table 37. Novartis AG Business Overview Table 38. Novartis AG Gene Therapy in CNS Disorder Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Novartis AG Gene Therapy in CNS Disorder Product Portfolio Table 40. Novartis AG Recent Development Table 41. Biogen Company Information Table 42. Biogen Business Overview Table 43. Biogen Gene Therapy in CNS Disorder Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Biogen Gene Therapy in CNS Disorder Product Portfolio Table 45. Biogen Recent Development Table 46. Voyager Therapeutics Company Information Table 47. Voyager Therapeutics Business Overview Table 48. Voyager Therapeutics Gene Therapy in CNS Disorder Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Voyager Therapeutics Gene Therapy in CNS Disorder Product Portfolio Table 50. Voyager Therapeutics Recent Development Table 51. Spark Therapeutics Company Information Table 52. Spark Therapeutics Business Overview Table 53. Spark Therapeutics Gene Therapy in CNS Disorder Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Spark Therapeutics Gene Therapy in CNS Disorder Product Portfolio Table 55. Spark Therapeutics Recent Development Table 56. Bluebird Bio Inc. Company Information Table 57. Bluebird Bio Inc. Business Overview Table 58. Bluebird Bio Inc. Gene Therapy in CNS Disorder Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Bluebird Bio Inc. Gene Therapy in CNS Disorder Product Portfolio Table 60. Bluebird Bio Inc. Recent Development Table 61. North America Gene Therapy in CNS Disorder Market Size by Type (2021-2026) & (US$ Million) Table 62. North America Gene Therapy in CNS Disorder Market Size by Type (2027-2032) & (US$ Million) Table 63. North America Gene Therapy in CNS Disorder Market Size by Application (2021-2026) & (US$ Million) Table 64. North America Gene Therapy in CNS Disorder Market Size by Application (2027-2032) & (US$ Million) Table 65. North America Gene Therapy in CNS Disorder Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 66. North America Gene Therapy in CNS Disorder Market Size by Country (2021-2026) Table 67. North America Gene Therapy in CNS Disorder Market Size by Country (2027-2032) Table 68. Europe Gene Therapy in CNS Disorder Market Size by Type (2021-2026) & (US$ Million) Table 69. Europe Gene Therapy in CNS Disorder Market Size by Type (2027-2032) & (US$ Million) Table 70. Europe Gene Therapy in CNS Disorder Market Size by Application (2021-2026) & (US$ Million) Table 71. Europe Gene Therapy in CNS Disorder Market Size by Application (2027-2032) & (US$ Million) Table 72. Europe Gene Therapy in CNS Disorder Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 73. Europe Gene Therapy in CNS Disorder Market Size by Country (2021-2026) Table 74. Europe Gene Therapy in CNS Disorder Market Size by Country (2027-2032) Table 75. China Gene Therapy in CNS Disorder Market Size by Type (2021-2026) & (US$ Million) Table 76. China Gene Therapy in CNS Disorder Market Size by Type (2027-2032) & (US$ Million) Table 77. China Gene Therapy in CNS Disorder Market Size by Application (2021-2026) & (US$ Million) Table 78. China Gene Therapy in CNS Disorder Market Size by Application (2027-2032) & (US$ Million) Table 79. Asia Gene Therapy in CNS Disorder Market Size by Type (2021-2026) & (US$ Million) Table 80. Asia Gene Therapy in CNS Disorder Market Size by Type (2027-2032) & (US$ Million) Table 81. Asia Gene Therapy in CNS Disorder Market Size by Application (2021-2026) & (US$ Million) Table 82. Asia Gene Therapy in CNS Disorder Market Size by Application (2027-2032) & (US$ Million) Table 83. Asia Gene Therapy in CNS Disorder Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. Asia Gene Therapy in CNS Disorder Market Size by Country (2021-2026) Table 85. Asia Gene Therapy in CNS Disorder Market Size by Country (2027-2032) Table 86. South America, Middle East & Africa Gene Therapy in CNS Disorder Market Size by Type (2021-2026) & (US$ Million) Table 87. South America, Middle East & Africa Gene Therapy in CNS Disorder Market Size by Type (2027-2032) & (US$ Million) Table 88. South America, Middle East & Africa Gene Therapy in CNS Disorder Market Size by Application (2021-2026) & (US$ Million) Table 89. South America, Middle East & Africa Gene Therapy in CNS Disorder Market Size by Application (2027-2032) & (US$ Million) Table 90. South America, Middle East & Africa Gene Therapy in CNS Disorder Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. South America, Middle East & Africa Gene Therapy in CNS Disorder Market Size by Country (2021-2026) Table 92. South America, Middle East & Africa Gene Therapy in CNS Disorder Market Size by Country (2027-2032) Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Gene Therapy in CNS Disorder Product Image Figure 2. Global Gene Therapy in CNS Disorder Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Gene Therapy in CNS Disorder Market Share by Type: 2025 VS 2032 Figure 4. Viral Gene Therapy Image Figure 5. Non-viral Gene Therapy Image Figure 6. Global Gene Therapy in CNS Disorder Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Gene Therapy in CNS Disorder Market Share by Application: 2025 VS 2032 Figure 8. Parkinson's Disease Image Figure 9. Huntington's Disease Image Figure 10. Batten Disease Image Figure 11. Alzheimer's Disease Image Figure 12. Global Gene Therapy in CNS Disorder Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 14. Global Gene Therapy in CNS Disorder Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Gene Therapy in CNS Disorder Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Gene Therapy in CNS Disorder Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Gene Therapy in CNS Disorder Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Gene Therapy in CNS Disorder Revenue Market Share by Type (2021-2032) Figure 21. Global Gene Therapy in CNS Disorder Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Gene Therapy in CNS Disorder Revenue Market Share by Application (2021-2032) Figure 23. North America Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 24. North America Gene Therapy in CNS Disorder Market Share by Type (2021-2032) Figure 25. North America Gene Therapy in CNS Disorder Market Share by Application (2021-2032) Figure 26. North America Gene Therapy in CNS Disorder Market Share by Country (2021-2032) Figure 27. United States Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 28. Canada Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 30. Europe Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 31. Europe Gene Therapy in CNS Disorder Market Share by Type (2021-2032) Figure 32. Europe Gene Therapy in CNS Disorder Market Share by Application (2021-2032) Figure 33. Europe Gene Therapy in CNS Disorder Market Share by Country (2021-2032) Figure 34. Germany Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 35. France Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 37. Italy Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 38. Russia Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 40. China Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 41. China Gene Therapy in CNS Disorder Market Share by Type (2021-2032) Figure 42. China Gene Therapy in CNS Disorder Market Share by Application (2021-2032) Figure 43. Asia Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 44. Asia Gene Therapy in CNS Disorder Market Share by Type (2021-2032) Figure 45. Asia Gene Therapy in CNS Disorder Market Share by Application (2021-2032) Figure 46. Asia Gene Therapy in CNS Disorder Market Share by Country (2021-2032) Figure 47. Japan Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 51. India Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 52. Australia Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Gene Therapy in CNS Disorder Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Gene Therapy in CNS Disorder Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Gene Therapy in CNS Disorder Market Share by Country (2021-2032) Figure 57. Brazil Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 62. UAE Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 64. Chile Gene Therapy in CNS Disorder Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Viral Gene Therapy
  • Non-viral Gene Therapy
Applications
  • Parkinson's Disease
  • Huntington's Disease
  • Batten Disease
  • Alzheimer's Disease
Companies covered
  • Novartis AG
  • Biogen
  • Voyager Therapeutics
  • Spark Therapeutics
  • Bluebird Bio Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Gene Therapy in CNS Disorder Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Viral Gene Therapy
  5. 1.2.3 Non-viral Gene Therapy
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Gene Therapy in CNS Disorder Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Parkinson's Disease
  9. 1.3.3 Huntington's Disease
  10. 1.3.4 Batten Disease
  11. 1.3.5 Alzheimer's Disease
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Gene Therapy in CNS Disorder Growth Trends by Region
  14. 1.5.1 Global Gene Therapy in CNS Disorder Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Gene Therapy in CNS Disorder Market Size by Region (2021-2026)
  16. 1.5.3 Gene Therapy in CNS Disorder Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Gene Therapy in CNS Disorder Market Dynamics
  1. 2.1 Gene Therapy in CNS Disorder Industry Trends
  2. 2.2 Gene Therapy in CNS Disorder Industry Drivers
  3. 2.3 Gene Therapy in CNS Disorder Industry Opportunities and Challenges
  4. 2.4 Gene Therapy in CNS Disorder Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Gene Therapy in CNS Disorder Revenue by Company (2021-2026)
  2. 3.2 Global Gene Therapy in CNS Disorder Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Gene Therapy in CNS Disorder Key Company Head office and Area Served
  4. 3.4 Global Gene Therapy in CNS Disorder Company, Product Type & Application
  5. 3.5 Global Gene Therapy in CNS Disorder Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Gene Therapy in CNS Disorder Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Gene Therapy in CNS Disorder Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Gene Therapy in CNS Disorder Tier 1, Tier 2, and Tier 3
4 Gene Therapy in CNS Disorder Market by Type
  1. 4.1 Global Gene Therapy in CNS Disorder Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Gene Therapy in CNS Disorder Market Size by Type (2021-2032)
  3. 4.3 Global Gene Therapy in CNS Disorder Market Size Share by Type (2021-2032)
5 Gene Therapy in CNS Disorder Market by Application
  1. 5.1 Global Gene Therapy in CNS Disorder Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Gene Therapy in CNS Disorder Market Size by Application (2021-2032)
  3. 5.3 Global Gene Therapy in CNS Disorder Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Gene Therapy in CNS Disorder Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Novartis AG Gene Therapy in CNS Disorder Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Biogen
  8. 6.2.1 Biogen Company Information
  9. 6.2.2 Biogen Business Overview
  10. 6.2.3 Biogen Gene Therapy in CNS Disorder Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Biogen Gene Therapy in CNS Disorder Product Portfolio
  12. 6.2.5 Biogen Recent Developments
  13. 6.3 Voyager Therapeutics
  14. 6.3.1 Voyager Therapeutics Company Information
  15. 6.3.2 Voyager Therapeutics Business Overview
  16. 6.3.3 Voyager Therapeutics Gene Therapy in CNS Disorder Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Voyager Therapeutics Gene Therapy in CNS Disorder Product Portfolio
  18. 6.3.5 Voyager Therapeutics Recent Developments
  19. 6.4 Spark Therapeutics
  20. 6.4.1 Spark Therapeutics Company Information
  21. 6.4.2 Spark Therapeutics Business Overview
  22. 6.4.3 Spark Therapeutics Gene Therapy in CNS Disorder Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Spark Therapeutics Gene Therapy in CNS Disorder Product Portfolio
  24. 6.4.5 Spark Therapeutics Recent Developments
  25. 6.5 Bluebird Bio Inc.
  26. 6.5.1 Bluebird Bio Inc. Company Information
  27. 6.5.2 Bluebird Bio Inc. Business Overview
  28. 6.5.3 Bluebird Bio Inc. Gene Therapy in CNS Disorder Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Bluebird Bio Inc. Gene Therapy in CNS Disorder Product Portfolio
  30. 6.5.5 Bluebird Bio Inc. Recent Developments
7 North America
  1. 7.1 North America Gene Therapy in CNS Disorder Market Size (2021-2032)
  2. 7.2 North America Gene Therapy in CNS Disorder Market Size by Type
  3. 7.2.1 North America Gene Therapy in CNS Disorder Market Size by Type (2021-2026)
  4. 7.2.2 North America Gene Therapy in CNS Disorder Market Size by Type (2027-2032)
  5. 7.2.3 North America Gene Therapy in CNS Disorder Market Share by Type (2021-2032)
  6. 7.3 North America Gene Therapy in CNS Disorder Market Size by Application
  7. 7.3.1 North America Gene Therapy in CNS Disorder Market Size by Application (2021-2026)
  8. 7.3.2 North America Gene Therapy in CNS Disorder Market Size by Application (2027-2032)
  9. 7.3.3 North America Gene Therapy in CNS Disorder Market Share by Application (2021-2032)
  10. 7.4 North America Gene Therapy in CNS Disorder Market Size by Country
  11. 7.4.1 North America Gene Therapy in CNS Disorder Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Gene Therapy in CNS Disorder Market Size by Country (2021-2026)
  13. 7.4.3 North America Gene Therapy in CNS Disorder Market Size by Country (2027-2032)
  14. 7.4.4 North America Gene Therapy in CNS Disorder Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Gene Therapy in CNS Disorder Market Size (2021-2032)
  2. 8.2 Europe Gene Therapy in CNS Disorder Market Size by Type
  3. 8.2.1 Europe Gene Therapy in CNS Disorder Market Size by Type (2021-2026)
  4. 8.2.2 Europe Gene Therapy in CNS Disorder Market Size by Type (2027-2032)
  5. 8.2.3 Europe Gene Therapy in CNS Disorder Market Share by Type (2021-2032)
  6. 8.3 Europe Gene Therapy in CNS Disorder Market Size by Application
  7. 8.3.1 Europe Gene Therapy in CNS Disorder Market Size by Application (2021-2026)
  8. 8.3.2 Europe Gene Therapy in CNS Disorder Market Size by Application (2027-2032)
  9. 8.3.3 Europe Gene Therapy in CNS Disorder Market Share by Application (2021-2032)
  10. 8.4 Europe Gene Therapy in CNS Disorder Market Size by Country
  11. 8.4.1 Europe Gene Therapy in CNS Disorder Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Gene Therapy in CNS Disorder Market Size by Country (2021-2026)
  13. 8.4.3 Europe Gene Therapy in CNS Disorder Market Size by Country (2027-2032)
  14. 8.4.4 Europe Gene Therapy in CNS Disorder Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Gene Therapy in CNS Disorder Market Size (2021-2032)
  2. 9.2 China Gene Therapy in CNS Disorder Market Size by Type
  3. 9.2.1 China Gene Therapy in CNS Disorder Market Size by Type (2021-2026)
  4. 9.2.2 China Gene Therapy in CNS Disorder Market Size by Type (2027-2032)
  5. 9.2.3 China Gene Therapy in CNS Disorder Market Share by Type (2021-2032)
  6. 9.3 China Gene Therapy in CNS Disorder Market Size by Application
  7. 9.3.1 China Gene Therapy in CNS Disorder Market Size by Application (2021-2026)
  8. 9.3.2 China Gene Therapy in CNS Disorder Market Size by Application (2027-2032)
  9. 9.3.3 China Gene Therapy in CNS Disorder Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Gene Therapy in CNS Disorder Market Size (2021-2032)
  2. 10.2 Asia Gene Therapy in CNS Disorder Market Size by Type
  3. 10.2.1 Asia Gene Therapy in CNS Disorder Market Size by Type (2021-2026)
  4. 10.2.2 Asia Gene Therapy in CNS Disorder Market Size by Type (2027-2032)
  5. 10.2.3 Asia Gene Therapy in CNS Disorder Market Share by Type (2021-2032)
  6. 10.3 Asia Gene Therapy in CNS Disorder Market Size by Application
  7. 10.3.1 Asia Gene Therapy in CNS Disorder Market Size by Application (2021-2026)
  8. 10.3.2 Asia Gene Therapy in CNS Disorder Market Size by Application (2027-2032)
  9. 10.3.3 Asia Gene Therapy in CNS Disorder Market Share by Application (2021-2032)
  10. 10.4 Asia Gene Therapy in CNS Disorder Market Size by Country
  11. 10.4.1 Asia Gene Therapy in CNS Disorder Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Gene Therapy in CNS Disorder Market Size by Country (2021-2026)
  13. 10.4.3 Asia Gene Therapy in CNS Disorder Market Size by Country (2027-2032)
  14. 10.4.4 Asia Gene Therapy in CNS Disorder Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Gene Therapy in CNS Disorder Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Gene Therapy in CNS Disorder Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Gene Therapy in CNS Disorder Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Gene Therapy in CNS Disorder Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Gene Therapy in CNS Disorder Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Gene Therapy in CNS Disorder Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Gene Therapy in CNS Disorder Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Gene Therapy in CNS Disorder Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Gene Therapy in CNS Disorder Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Gene Therapy in CNS Disorder Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Gene Therapy in CNS Disorder Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Gene Therapy in CNS Disorder Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Gene Therapy in CNS Disorder Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Gene Therapy in CNS Disorder Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst